Page last updated: 2024-09-03

ginsenoside rh2 and Adenocarcinoma Of Kidney

ginsenoside rh2 has been researched along with Adenocarcinoma Of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hong, SH; Hwang, HJ; Moon, HS; Park, SY; Yoon, YE1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Adenocarcinoma Of Kidney

ArticleYear
Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma.
    Scientific reports, 2022, 11-17, Volume: 12, Issue:1

    Topics: Carcinoma, Renal Cell; Cell Cycle Checkpoints; Ginsenosides; Humans; Kidney Neoplasms; Sunitinib

2022